
Cardiovascular Systems CSII
Quarterly report 2022-Q4
added 02-09-2023
Country |
|
IPO year |
1981 |
Industry |
Medical devices |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
39.2 M |
Market Cap[1] |
$ 844 M |
EBITDA (LTM) |
$ -45.1 M |
P/E (LTM) |
- |
P/S (LTM) |
2.83 |
EPS (LTM) |
-1.19 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Abiomed
ABMD
|
- | - | $ 17.2 B | Nasdaq Global Select Market,SPB | ||
|
Alphatec Holdings
ATEC
|
$ 21.01 | 0.21 % | $ 3 B | Nasdaq Global Select Market | ||
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Cognyte Software Ltd.
CGNT
|
$ 9.28 | -0.32 % | $ 666 M | Nasdaq Global Select Market,SPB | ||
|
Apyx Medical Corporation
APYX
|
$ 3.5 | 1.74 % | $ 121 M | Nasdaq Global Select Market | ||
|
Boston Scientific Corporation
BSX
|
$ 95.63 | -0.45 % | $ 141 B | NYSE,SPB | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Bio-Rad Laboratories
BIO
|
$ 302.5 | -0.45 % | $ 8.53 B | NYSE,SPB | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
Cutera
CUTR
|
- | -10.19 % | $ 1.99 M | Nasdaq Global Select Market | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
Electromed
ELMD
|
$ 28.43 | -0.25 % | $ 240 M | NYSE American | ||
|
Bruker Corporation
BRKR
|
$ 48.11 | 0.21 % | $ 7.17 K | Nasdaq Global Select Market,SPB | ||
|
Abbott Laboratories
ABT
|
$ 124.79 | -0.04 % | $ 217 B | NYSE,SPB | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
EDAP TMS S.A.
EDAP
|
$ 3.3 | -2.81 % | $ 123 M | Nasdaq Global Market | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
InMode Ltd.
INMD
|
$ 14.73 | 0.75 % | $ 1.17 B | Nasdaq Global Select Market,SPB | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
IRIDEX Corporation
IRIX
|
$ 1.15 | -6.5 % | $ 18.5 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
IRadimed Corporation
IRMD
|
$ 97.76 | 0.32 % | $ 1.24 B | Nasdaq Global Select Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
LivaNova PLC
LIVN
|
$ 62.05 | -1.31 % | $ 3.37 B | Nasdaq Global Select Market | ||
|
LENSAR
LNSR
|
$ 11.99 | 0.33 % | $ 138 M | Nasdaq Capital Market | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
Align Technology
ALGN
|
$ 157.62 | -0.47 % | $ 11.8 B | Nasdaq Global Select Market,SPB | ||
|
NanoVibronix
NAOV
|
- | - | $ 1.08 M | Nasdaq Global Select Market | ||
|
Accuray Incorporated
ARAY
|
$ 0.78 | -5.74 % | $ 80.2 M | Nasdaq Global Select Market | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
ClearPoint Neuro
CLPT
|
$ 13.54 | -3.42 % | $ 366 M | Nasdaq Capital Market | ||
|
FONAR Corporation
FONR
|
$ 14.52 | 0.48 % | $ 95.2 M | Nasdaq Capital Market | ||
|
AxoGen
AXGN
|
$ 32.71 | -0.29 % | $ 1.45 B | Nasdaq Capital Market,SPB | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
CONMED Corporation
CNMD
|
$ 41.15 | 0.86 % | $ 1.27 B | NYSE,SPB | ||
|
Orthofix Medical
OFIX
|
$ 15.33 | 0.59 % | $ 585 M | Nasdaq Global Select Market,SPB | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 17.55 | 1.21 % | $ 405 M | Nasdaq Global Select Market,SPB | ||
|
Globus Medical
GMED
|
$ 88.49 | 0.09 % | $ 12 B | NYSE,SPB | ||
|
Integra LifeSciences Holdings Corporation
IART
|
$ 12.56 | -0.52 % | $ 967 M | Nasdaq Global Select Market,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.